Trehalose dimycolate is a glycolipid component of the cell walls of mycobacteria, nocardia, and corynebacteria. When trehalose dimycolate is injected into certain strains of mice, they develop interstitial pneumonitis that is characterized by mononuclear cell infiltration of the alveolar walls, intra-alveolar hemorrhages, and in some animals, granuloma formation. The disorder is seldom fatal, and in approximately 4 weeks, the lungs are normal. There is strong evidence that T lymphocytes are essential for production of interstitial pneumonitis by trehalose dimycolate, but little is known about the mechanisms of lung injury in this model. The experiments described in this report were conducted to identify the roles of the various cells that accumulate in the lungs of mice with this form of interstitial pneumonitis. We found that Mac3+ macrophages were the first cells to appear in the alveolar walls. Increases in the number of L3T4+ T lymphocytes, Lyt2+ T lymphocytes, and surface-immunoglobulin-positive lymphocytes followed, but significant increases in the number of lymphoid cells were not observed until day 7, when the pulmonary lesions were well developed. Treatment of the mice with cyclophosphamide or anti-T-cell sera significantly reduced the number of lymphoid cells in the alveolar walls but did not affect the number of Mac3+ cells and did not affect development of intra-alveolar hemorrhages. Treatment with poly(I C) significantly decreased the number of Mac3+ cells in the lungs, and these mice did not develop pulmonary hemorrhages. We conclude that although development of pulmonary lesions in trehalose dimycolate-treated mice is a T-cell-dependent process, macrophages are also essential and are more directly involved in production of the lung injury. We postulate that the lung lesions are the direct effect of macrophage-produced cytokines, such as tumor necrosis factor.
Trehalose dimycolate (TDM) is a glycolipid component of the cell walls of mycobacteria, nocardia, and corynebacteria. Intraperitoneal injection of TDM into susceptible strains of mice produces cellular infiltrations and hemorrhages in the lungs but no lesions in other organs (13) (14) (15) . The interstitial inflammation becomes maximal approximately 7 days after injection of TDM before spontaneous recovery occurs, and by 4 weeks after injection, the mice have normal lungs (13) . The disorder has a low mortality rate despite the extensive pulmonary abnormalities. Thus, TDM-induced interstitial pneumonitis of mice provides a unique experimental model for studying the mechanisms of certain interstitial lung diseases.
The pathogenesis of TDM-induced interstitial pneumonitis is only partially understood. There is strong evidence favoring a role for T lymphocytes (14) . Homozygous C57BL/10 nude mice do not develop pulmonary lesions after injection of TDM unless they are first reconstituted with splenic T cells from syngeneic normal donors (14) . Moreover, reserpine, a drug that inhibits expression of T-cell-dependent immune functions (5) (probably through a direct action on T lymphocytes [9] ), also prevents TDM-induced lung injury (15) .
Histological and ultrastructural studies of the interstitial pulmonary infiltrates have shown that the infiltrates are composed of lymphocytes and macrophages (13) . The experiments described in this report were directed at defining the phenotypes of the infiltrating cells in the lungs of mice with TDM-induced interstitial pneumonitis. Serial assessments of the lungs were performed throughout the course of development of the lesions. The effects of antibodies, cyclophosphamide, and an inducer of interferon production were also studied.
MATERIALS AND METHODS
Mice. These experiments were conducted in C57BL/lOSn mice that are highly susceptible to the interstitial pneumonitis produced by TDM (1, 2) and in BALB/cBy mice that are not susceptible to TDM-induced lung injury. The mice were of either sex and were aged 6 to 8 weeks. They were purchased either from Jackson Laboratory (Bar Harbor, Maine) or from the animal production facility of the National Jewish Center for Immunology and Respiratory Medicine.
Reagents. Pure TDM was prepared from Mycobacterium tuberculosis (peurois) by the late R. Toubiana by the method of Noll (10) . The homogeneity of the material was confirmed by thin-layer chromatography and by the characteristic infrared spectrum (7) . Cyclophosphamide (Cytoxan) was purchased from Mead Johnson Laboratories (Evansville, Ind.). Poly(I C) was purchased from Sigma Chemical Co. (St. Louis, Mo.). Other reagents were obtained from various sources as described below.
Production of interstitial pneumonitis. (Fig. 2) .
Phenotypic analysis of infiltrating cells. The goal of these experiments was to characterize the cells in the infiltrates to obtain more information about possible mechanisms of injury to the lung. Mice were injected with 10 ,ug of TDM in 100 ,ul of Marcol 52 on day 1. On days 1 (6 h after injection of TDM), 2, 3, 5, and 7, randomly selected mice were sacrificed for study. Each datum point represents six to eight mice. The findings were compared with age-matched syngeneic mice that were injected with Marcol 52 alone.
The morphometric analyses showed that no significant changes occurred in the populations of Thyl.2+ T lymphocytes or surface-immunoglobulin-positive B lymphocytes at 6 h (day 1) after injection of TDM (Fig. 3) . These findings are in keeping with our previously reported histologic studies of TDM-induced interstitial lung disease (12, 13) . By day 2, the number of lymphocytes and macrophages in the pulmonary interstitium had decreased, and for Thyl.2+ T cells and surface-immunoglobulin-positive B cells, the decreases were significant. The number of T cells decreased from 244.9 ± 29.6 to 132. During days 3 through 7, the cellularity of the interstitium increased progressively (Fig. 3) . By days 3, 5, and 7, the numbers of macrophages in the infiltrates were significantly greater than those for the Marcol 52-treated control mice. The phenotypes of the infiltrating T cells were analyzed (Fig. 4) . The reduction in total infiltrating T cells that was noted on day 2 was due to decreases in both L3T4+ and Lyt2+ cells. During days 5 and 7, the numbers of T lymphocytes in the infiltrates increased, and for both the L3T4+ and Lyt2+ cells, the values at day 7 were significantly greater than those for the control mice.
Effect of cyclophosphamide on cellular infiltrates. Cyclophosphamide was dissolved in distilled water and a dose of 200 mg/kg was given intraperitoneally 2 days before injection of 10 pLg of TDM in 100 ,ug of Marcol 52 or 100 1LI of Marcol 52 alone. There were seven mice in each treatment group. All mice were sacrificed for morphometric analysis of cellular infiltrates on day 7. Cyclophosphamide pretreatment markedly reduced the number of lymphoid cells in the interstitia of the lungs of both the TDM-treated and the Marcol 52-treated mice (Fig. 5) . In fact, on day 7 the number of L3T4+ cells in the lungs of the TDM-treated mice was even less than that for the Marcol 52-treated controls (62. (Fig. 5) ; these findings were in marked contrast to the findings on day 7 in mice that did not receive cyclophosphamide ( Fig. 3 and 4) .
On the other hand, cyclophosphamide pretreatment did not affect infiltration of the lungs of TDM-treated mice with macrophages (Mac3+) (Fig. 5) Effect of in vivo treatment with antibodies on the pathogenesis of TDM-induced interstitial pneumonitis. To study the effects of anti-asialo GM1, mice were given 20 ,ul of the concentrated antiserum in 200 ,ul of HBSS intravenously on the day before (day 0) and days 3 and 5 after intraperitoneal injection of 10 ,ug of TDM in 100 ,u1 of Marcol 52. For the experiments with anti-L3T4 and anti-Lyt2.2, 2 mg of purified antibody was injected intravenously 8 days before TDM injection and 2 mg was injected intraperitoneally 3 days before and 3 days after injection of TDM in Marcol 52. Control mice received the antibodies according to the same schedules and were given only Marcol 52. Mice were sacrificed on day 7 for morphometric analysis (left lung) and for quantitation of pulmonary hemorrhages with "1In-RBCs (right lung).
The duration of the effects of antibody treatment on the populations of cells in lymph nodes and spleens was studied in mice that did not receive TDM. These mice were sacrificed either 1 day before administration of TDM to the other mice (day 0) or the day after sacrifice of the TDM-treated mice (day 8). The findings in these mice were compared with the findings in mice that had been treated with PBS according to the same schedule.
Administration of anti-L3T4 or anti-Lyt2.2 completely ablated detectable L3T4+ or Lyt2+ cells from the lymph nodes and either markedly reduced the percentage or eliminated positive cells in the spleens (Table 1) . These effects persisted throughout the duration of the studies with TDM, as they were still present in the mice that were sacrificed on day 8, the day after sacrifice of the TDM-treated mice.
The effect of treatment with monoclonal antibodies on the cellular composition of the pulmonary lesions in TDMtreated mice was also evaluated. Figure 6 shows that treatments that were effective in reducing the number of demonstrable L3T4+ or Lyt2+ cells in the spleens and lymph nodes also markedly reduced the number of cells of the appropriate phenotypes in the interstitia of the lungs. For example, the anti-L3T4-treated mice had only 25.7 + 3.5 L3T4+ cells per mm2 of pulmonary interstitium, significantly less than the However, neither treatment with the anti-T-cell antisera affected infiltration of the interstitium with macrophages (Fig. 6 ). The numbers of macrophages per millimeter2 in anti-L3T4-treated, anti-Lyt2.2-treated, or untreated control mice were 3,348 ± 441, 3,312 ± 381, and 3,578 ± 362, respectively. Moreover, despite the marked reduction of infiltrating T lymphocytes, monoclonal antibody treatment did not alter development of hemorrhages in the lungs of TDM-treated mice. Macroscopic hemorrhages were found in three of seven TDM-treated control mice, four of six anti-L3T4-treated, TDM-treated mice, and five of six anti-Lyt2.2-treated, TDM-treated mice. By the "1In-RBC assay, the hemorrhages in three of the anti-Lyt2-treated mice were greater than those in any of the control or anti-L3T4-treated mice (Fig. 7) . It should be noted, however, that although the 111In-RBC assay was useful for mice that had extensive pulmonary hemorrhages, it was less sensitive than direct observation for mice with multiple pinpoint or patchy areas of hemorrhage into the lung.
A similar experiment was done in which mice (n = 6) were treated with both anti-L3T4 and anti-Lyt2.2 antisera according to the schedule described above. These mice did not have identifiable lymph nodes when they were sacrificed on day 7 . Flow cytometric analysis of their spleen cells showed marked depletion of all T lymphocytes ( Table 2 ). All of the TDM-treated control mice and three of the six antibodytested, TDM-treated mice developed pulmonary hemorrhages by day 7. Two studies of the effect of a commercial anti-asialo GM1 antiserum were done. In both experiments, all six anti-asialo GM1-treated mice developed pulmonary hemorrhages and were comparable with the control mice. There were no significant differences in the number of macrophages (Mac3+) in the infiltrates in the lungs of these mice (3, Effect of treatment with poly(I C) on development of interstitial pneumonitis in TDM-treated mice. Intraperitoneal injection of 100 ,ug of poly(I C) 2 days before intraperitoneal injection of 10 pg of TDM did not alter the course or intensity of the TDM-induced pulmonary lesions. However, when poly(I C) was injected on day 3 or on days 3 and 5, none of the recipients of TDM developed pulmonary hemorrhages by either microscopic, macroscopic, or "'In-RBC analyses (Fig. 8) . Four of the five control mice that received TDM alone had macroscopic pulmonary hemorrhages of score 3 or greater. Moreover, mice that were given poly(I C) had significantly fewer macrophages in their pulmonary lesions than the controls (1,616 ± 72 macrophages per mm2 in controls versus 1,344 ± 61 macrophages per mm2 in poly(I C)-treated mice [P = 0.02]).
Phenotypes of cells in the pulmonary interstitia of TDMinsensitive BALB/c mice. The effects of intraperitoneal injection of 10 pg of TDM in 100 ,ul of Marcol 52 on pulmonary histology was also studied in BALB/cBy mice, a strain that is not susceptible to TDM-induced interstitial pneumonitis. These mice did not develop pulmonary hemorrhages, and these mice did not show the pulmonary infiltrates that occur in susceptible mice (Table 3) . DISCUSSION In the early 1950's, the late Hubert Bloch reported that repeated intraperitoneal injections of partially purified cord factor from tubercle bacilli caused weight loss and death in susceptible strains of mice (1, 2) . The lungs of the mice were grossly hemorrhagic at autopsy. Subsequently we described the natural history of cord factor-induced interstitial pneumonitis (13) . The first lesions in the lungs are mononuclear cell infiltrations in the alveolar septae and appear on day 3. These increase in intensity and become maximal about day 7, after which they slowly subside over the next 14 days. By day 28, the mice have normal lungs. Intra-alveolar hemorrhages are also part of this syndrome; they are first noted about day 5 and also become maximal on day 7, when 60 to These data could provide insights into the mechanisms of lung injury in this model. The earliest significant change in the histology of the lungs of TDM-treated mice was a transitory decrease in the numbers of L3T4+, Lyt2+, and surface-immunoglobulinpositive lymphocytes on day 2. The mechanism of this effect has not been determined, but the finding was consistent. By day 3, the numbers of L3T4+ cells and surface-immunoglobulin-positive cells had returned to the baseline values, but the decrease in the number of Lyt2+ cells was still present.
At this time, there was also a significant increase in the number of cells that were Mac3+ and therefore had the phenotype of macrophages. Cells of this phenotype increased on days 5 and 7 and constituted the majority (83% of cells on day 5 and 78% of cells on day 7) of the cells in the interstitium throughout the duration of the experiments. Significant increases in the numbers of lymphoid cells (L3T4+, Lyt2+, and surface immunoglobulin positive) did not occur until day 7, when the pulmonary lesions were well developed. In addition, by day 7 approximately 60 to 70% of the mice also had localized or diffuse hemorrhages into the alveolar spaces. Despite the extensive pulmonary lesions, the mortality in mice treated with a single injection of 10 ,ug of TDM is low (approximately 10%). It is noteworthy that mice treated with TDM do not have pulmonary infiltrates with neutrophils (12) and during recovery do not have fibrin deposition, proliferation of connective tissue in the alveolar walls, or proliferation of type II alveolar cells (13) ; in these respects the changes produced by TDM differ from other models of interstitial lung disease (18) .
Previous experiments with this model had provided evidence that T lymphocytes had an important role in the pathogenesis of TDM-induced pulmonary lesions (14, 15) . Athymic nude mice that are derived from TDM-sensitive strains do not develop interstitial pneumonitis unless they are reconstituted with T-lymphocyte-enriched preparations of syngeneic spleen cells (14) . Moreover, reserpine, a potent inhibitor of T-lymphocyte functions (9), markedly reduces development of pulmonary lesions in TDM-treated mice (15) . Although the evidence is indirect, a role for cellular elements of the immune response is also implied from our recent studies that failed to provide evidence that immunoglobulins or the complement system play any role in the production of pulmonary lesions in TDM-treated mice (12) .
The experiments described in this report were conducted to further define the composition of the interstitial infiltrates during development of pneumonitis in TDM-treated mice. From the observations in the nude mice, we anticipated that the early infiltrates would consist of T lymphocytes, but this was not the case. Instead, the most numerous cells and the cells that had the strongest concordance with development of intra-alveolar hemorrhages were Mac3+ macrophages. Even when the numbers of T lymphocytes and B lymphocytes were markedly reduced by treatment of the mice with cyclophosphamide or anti-lymphocyte sera, large numbers of Mac3+ cells were still present in the alveolar walls of TDM-treated mice, and these mice developed pulmonary hemorrhages.
There were two exceptions to this observation. Mice that were treated with both anti-L3T4 and anti-Lyt2 had very few T lymphocytes in their lungs and lymphoid tissues, and only three of six of these mice developed pulmonary hemorrhages, while hemorrhages were present in all six TDMtreated controls. The other treatment that prevented development of pulmonary hemorrhages was administration of poly(I C). This treatment also significantly reduced the number of Mac3+ cells in the alveolar walls.
These findings suggest that macrophages or a macrophagederived cytokine(s) may also be essential for production of lung injury. Candidate molecules include interleukin 1 and tumor necrosis factor (cachectin) (3, 11) . A role for the latter substance is an attractive possibility, and none of our data would contradict this hypothesis. It is noteworthy that Valone and associates (19) have shown that addition of a variety of mycobacterial components to cultures of human blood monocytes or alveolar macrophages stimulated secretion of tumor necrosis factor into the culture fluids. Silva et al. (16, 17) have shown that cord factors from Mycobacterium bovis and Nocardia asteroides produce cachexia in mice in a manner similar to that observed earlier by Bloch and co-workers (1, 2) . Although the lungs of the cord factor-treated mice were not described in the report of Silva and Faccioli (16) , when plasma from these mice was transferred to untreated mice, the recipients had weight loss and diarrhea and developed unkempt appearances; their lungs showed severe interstitial pneumonitis.
From our data and from the observations of others, we must propose a more complex mechanism for the pathogenesis of interstitial pneumonitis in TDM-treated mice. The observations in the nude mice (14) and in the reserpinetreated mice (15) provide strong evidence that the process is T cell dependent. Treatment with cyclophosphamide and anti-lymphocyte sera reduced the numbers of T cells, but apparently not to a degree that prevented development of lesions. However, more marked reduction in the number of T cells by treatment with both anti-L3T4 and anti-Lyt2 was associated with fewer pulmonary hemorrhages.
Our data also suggest that production of the pulmonary lesions is mediated by infiltrating macrophages or their products. In this model, the T cells could provide the signal for production of the cytokine by macrophages in response to TDM or could be the source of a second cytokine that is an essential cofactor for induction of lung injury.
